Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NeuExcell, Spark Therapeutics enter collaboration to develop gene therapy for Huntington's disease

Sep. 7, 2021

Neurons derived from iPSCs capture encoded genetic risk for Alzheimer's disease

Sep. 7, 2021

NRG gearing up for series A to advance brain-penetrant PTP inhibitors

Sep. 6, 2021

Study elucidates how ApoE4 astrocytes influence neuronal amyloidosis

Sep. 6, 2021

New FPR2 agonists target inflammation in Alzheimer's disease

Sep. 3, 2021

New kratom derivatives identified with mu-opioid receptor modulatory activity

Sep. 3, 2021

Haim Bio synthesizes new antiepileptics

Sep. 3, 2021

Bristol Myers Squibb exercises option to Evotec's EVT-8683

Sep. 2, 2021

Discovery of novel potent and reversible MAGL inhibitors

Sep. 2, 2021

Discovery of novel GluN2B PAMs as potential therapeutics for Alzheimer's disease

Sep. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...